Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

ENCYSIVE PHARMACEUTICALS INC (ENCY)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-06Dec-31-05Dec-31-04Dec-31-03Dec-31-02
   10-K/A10-K/A10-K/A10-K10-K
Revenues  19.014.012.811.010.4
            Revenue growth  35.6%9.2%17.2%5.0% 
Cost of goods sold  0.10.00.029.428.6
Gross profit  18.914.012.8-18.4-18.2
            Gross margin  99.5%100.0%100.0%-168.1%-174.4%
Selling, general and administrative   [+]63.728.311.58.39.0
Research and development  64.463.556.4  
EBITDA   [+]-108.2-76.6-54.4-25.9-26.1
            EBITDA margin  -569.4%-546.7%-424.3%-236.9%-250.1%
Depreciation and amortization  1.11.20.70.71.1
EBIT   [+]-109.3-77.8-55.2-26.7-27.2
            EBIT margin  -575.3%-555.4%-430.0%-243.6%-260.4%
Non-recurring items     8.4 
Interest expense  3.93.10.00.1 
Other income (expense), net  3.84.71.51.427.2
Pre-tax income  -109.4-76.2-53.7-33.80.0
Income taxes  -109.4-77.5-52.8-32.30.0
            Tax rate  100.0%101.8%98.3%95.5% 
Earnings from continuing ops  -109.3-76.2-53.7-33.8-23.5
Earnings from discontinued ops   1.3-0.9-1.5 
Net income  -109.3-74.9-54.7-35.3-23.5
            Net margin  -575.3%-534.6%-426.0%-322.3%-224.9%
   
Basic EPS   [+]($1,863.94)($1,314.93)($996.05)($0.77)($536.54)
Diluted EPS   [+]($1,863.94)($1,314.93)($996.05)($0.77)($536.54)
   
Shares outstanding (basic)   [+]0.10.10.144.10.0
Shares outstanding (diluted)   [+]0.10.10.144.10.0
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy